JOHN MRACHINA: Open Payments
NPI 1861957383 · CLINTON TOWNSHIP, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,354 in 45 payments from 10 companies in 2025. Trend: 2023 $668 · 2024 $1,225 · 2025 $1,354
Food & beverage: $1,354
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $505 |
| E.R. Squibb & Sons, L.L.C. | 4 | $182 |
| ABBVIE INC. | 9 | $179 |
| Otsuka America Pharmaceutical, Inc. | 14 | $161 |
| Neurocrine BioSciences, Inc. | 1 | $122 |
| Alkermes, Inc. | 4 | $97 |
| Supernus Pharmaceuticals, Inc. | 3 | $54 |
| OWP Pharmaceuticals, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: Auvelity, COBENFY, VRAYLAR, REXULTI, INGREZZA, LYBALVI, Qelbree, Sunosi.
Industry payments across MI — which companies pay providers there.
